W
William L. H. Whittington
Researcher at University of Washington
Publications - 89
Citations - 6359
William L. H. Whittington is an academic researcher from University of Washington. The author has contributed to research in topics: Sexually transmitted disease & Neisseria gonorrhoeae. The author has an hindex of 48, co-authored 89 publications receiving 6176 citations. Previous affiliations of William L. H. Whittington include Public Health – Seattle & King County & Florida Department of Health.
Papers
More filters
Journal ArticleDOI
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Connie Celum,Anna Wald,Anna Wald,J.R. Lingappa,Amalia Magaret,Amalia Magaret,Richard S. Wang,Nelly Mugo,Nelly Mugo,Andrew Mujugira,Jared M. Baeten,James I. Mullins,James P. Hughes,Elizabeth A. Bukusi,Elizabeth A. Bukusi,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,James Kiarie,Carey Farquhar,Grace John Stewart,Joseph Makhema,Myron Essex,Edwin Were,Kenneth H. Fife,G de Bruyn,Glenda Gray,James McIntyre,Rachel Manongi,Saidi Kapiga,David Coetzee,Susan Allen,Mubiana Inambao,Kayitesi Kayitenkore,Etienne Karita,William Kanweka,Sinead Delany,Helen Rees,Bellington Vwalika,Wendy S. Stevens,Campbell,Katherine K. Thomas,Robert W. Coombs,Rhoda Ashley Morrow,William L. H. Whittington,M J McElrath,M J McElrath,Linda E Barnes,Renee Ridzon,Lawrence Corey,Lawrence Corey +51 more
TL;DR: Daily acyclovir therapy did not reduce the risk of transmission of HIV-1, despite a reduction in plasma HIV- 1 RNA of 0.25 log(10) copies per milliliter and a 73% reduction in the occurrence of genital ulcers due to HSV-2.
Journal ArticleDOI
Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.
Matthew R. Golden,William L. H. Whittington,H. Hunter Handsfield,James P. Hughes,Walter E. Stamm,Matthew Hogben,Agnes Clark,Cheryl Malinski,Jennifer R. L. Helmers,Katherine K. Thomas,King K. Holmes +10 more
TL;DR: Expedited treatment of sex partners reduces the rates of persistent or recurrent gonorrhea or chlamydial infection and is significantly more likely than those assigned to standard referral of partners to report that all of their partners were treated and significantly less likely to report having sex with an untreated partner.
Journal ArticleDOI
Sexual mixing patterns in the spread of gonococcal and chlamydial infections.
Sevgi O. Aral,James P. Hughes,Bradley P. Stoner,William L. H. Whittington,H. Hunter Handsfield,Roy M. Anderson,King K. Holmes +6 more
TL;DR: Mixing patterns influence the risk of specific infections, and they should be included in risk assessments for individuals and in the design of screening, health education, and partner notification strategies for populations.
Journal ArticleDOI
Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial.
Julia A. Schillinger,Patricia Kissinger,Helene Calvet,William L. H. Whittington,Ray L Ransom,Maya R. Sternberg,Stuart M. Berman,Charlotte K. Kent,David H. Martin,M. Kim Oh,H. Hunter Handsfield,Gail Bolan,Lauri E. Markowitz,J. Dennis Fortenberry +13 more
TL;DR: Patient-delivered partner treatment for prevention of repeated C trachomatis infection among women is comparable to self-referral and may be an appropriate option for some patients.
Journal Article
Update to CDC's sexually transmitted diseases treatment guidelines, 2006
C Del Rio,Geraldine S. Hall,Edward W. Hook,King K. Holmes,William L. H. Whittington,Franklyn N. Judson,E. L. Yee,Alesia Harvey,K. P. Kramer,David L. Trees,R. Ballard,Kimberly A. Workowski,Lori M. Newman,Stuart M. Berman,Hillard Weinstock +14 more
TL;DR: On the basis of the most recent evidence, CDC no longer recommends the use of fluoroquinolones for the treatment of gonococcal infections and associated conditions such as pelvic inflammatory disease (PID).